Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03405753
Other study ID # Lab.Reprod.Biol.-Aronia
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2018
Est. completion date December 31, 2022

Study information

Verified date November 2023
Source Odense University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Intervention cross-over study during which participants receive standardized amounts of aronia berry tablets or placebo for three months, then wash out for three months, then aronia tablets or placebo for three months. The potential health effects are investigated. Following parameters are measured before and after each period of tablet intake: 1) Blood pressure, 2) Lipid fractions, 3) Testosterone, 4) Phase II markers, 5) HbA1c, 6) HSCRP, 7) F2-isoprostanes, and 8) semen quality.


Recruitment information / eligibility

Status Completed
Enrollment 109
Est. completion date December 31, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria: - Healthy men with total cholesterol between 5 and 7 mmol/L, who do not take medication Exclusion Criteria: - Chronic diseases and intake of medication or antioxidants

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Aronia, washout and then placebo
Three tablets three times à day for three months then washout for three months, then three placebo tablets three times à day for three months. Blood samples and semen samples collected before and after each period of tablet intake.
Placebo, washout and then aronia
Three tablets three times à day for three months, then washout for three months, then three aronia tablets three times à day for three months. Blood samples and semen samples collected before and after each period of tablet intake.

Locations

Country Name City State
Denmark Centre of Andrology & Fertility Clinic, Department D, Odense University Hospital Odense

Sponsors (1)

Lead Sponsor Collaborator
Odense University Hospital

Country where clinical trial is conducted

Denmark, 

References & Publications (1)

Sangild J, Faldborg A, Schousboe C, Fedder MDK, Christensen LP, Lausdahl AK, Arnspang EC, Gregersen S, Jakobsen HB, Knudsen UB, Fedder J. Effects of Chokeberries (Aronia spp.) on Cytoprotective and Cardiometabolic Markers and Semen Quality in 109 Mildly Hypercholesterolemic Danish Men: A Prospective, Double-Blinded, Randomized, Crossover Trial. J Clin Med. 2023 Jan 3;12(1):373. doi: 10.3390/jcm12010373. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Cholesterol HDL, LDL and total cholesterol in mmol/L 9 months
Secondary Phase II enzyme activity Glutathion in U/mL 9 months
Secondary Phase II enzyme activity Superoxid dismutase (SOD) in U/mL 9 months
Secondary Phase II enzyme activity Catalase (CAT) in U/mL 9 months
Secondary Isoprostanes Peroxidation of fatty acids measured in U/mL 9 months
Secondary Semen quality Sperm count in million/mL 9 months
Secondary Semen quality Motility in percent 9 months
Secondary Semen quality DNA fragmentation in percent 9 months
Secondary Blood pressure Systolic and diastolic blood pressure in mmHg 9 months
Secondary High Sensitivity C reactive protein Acute phase reactant in mg/L 9 months